近日，人工智能个性化手术医疗科技公司Carlsmed宣布完成由B Capital和US Venture Partners共同领投的5250万美元C轮融资。此次融资将加速推动Carlsmed的aprevo®个性化脊柱手术平台的商业化进程，并进一步开发用于颈椎融合手术的aprevo®平台，预计于2025年推出。Carlsmed致力于通过人工智能技术为患者提供个性化的手术解决方案，此次融资的成功将进一步巩固其在医疗科技领域的领先地位。
Title: Carlsmed Secures $52.5 Million in Series C Funding
Keywords: Artificial Intelligence, Medical Technology, Investment
News Content: Carlsmed, a leading AI-driven personalized surgical medical technology company, has announced the successful completion of a $52.5 million Series C funding round led by B Capital and US Venture Partners. The funds will be utilized to accelerate the commercialization of the company’s aprevo® personalized spinal surgery platform and the development of a new aprevo® platform designed for cervical fusion surgery, slated for launch in 2025. Carlsmed’s commitment to providing customized surgical solutions through AI technology is poised to be further solidified by this significant investment.
【来源】https://www.businesswire.com/news/home/20240318820510/en/Carlsmed-Raises-52.5M-in-Series-C-Financing-to-Advance-Personalized-Spine-Surgery
Views: 1